Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies
批准号:
10685245
负责人:
Andrew Carl Dudley
金额:
$42.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
未结题
起止时间:
1976-07-01 至 2027-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The Cancer Research Training Program (CRTP) at the University of Virginia brings together faculty and
trainees with a common interest in cancer biology to participate in an integrated program of cancer research,
education, and discovery. The overall objective of the CRTP is to empower the next generation of cancer
researchers with the tools to become future leaders in the quest to understand oncological processes and
improve patient outcomes. We accomplish these goals through intensive cancer research training coupled with
academic and professional development activities. Together, these provide the trainees with (1) a broad-based
knowledge of fundamental principles in cancer biology; (2) the ability to define and solve vital research
questions using the most current approaches and techniques in the constantly changing landscape of
biomedical research; and (3) the skills to partner with basic scientists, translational researchers, clinical
trialists, clinicians, and cancer patients/survivors to promote discovery and improved outcomes. This renewal
application incorporates a new leadership structure prompted by the addition of Dr. Andrew Dudley as part of a
multi-PI team with the current PI, Dr. Amy Bouton. We request support for 8 predoctoral trainees who will
participate in longitudinal training that includes laboratory research, formal course work, programmatic
activities, exposure to clinical/translational aspects of cancer, programming in professional/career
development, and community outreach opportunities. The 42 CRTP faculty mentors provide a robust and fully
integrated platform through which the program delivers this training. Most importantly, the CRTP takes
advantage of the robust cancer research community provided by the NCI-designated UVA Cancer Center. This
affords the trainees an opportunity to apply their own experiences in basic cancer research to the need for
improved diagnosis and treatments in cancer care. The CRTP has experienced much success over its almost
44-year history. As we move into the next funding period, we challenge ourselves to meet the changing
landscape of cancer research through constant assessment and evolution of the program. In this regard, we
have incorporated a number of new initiatives designed to reinforce community-building, provide new
opportunities for applied learning and professional development, and promote dialogues between trainees and
cancer patients/survivors. This renewal application also includes important new enhancements focused on
training in rigor and reproducibility, mentor training, and the establishment of an Advisory Committee for
Diversity & Inclusion. The full array of CRTP activities, together with a dedicated faculty, talented cadre of
trainees, and vibrant cancer research community, all contribute to producing CRTP alumni who are well-
positioned to become lifelong learners and future leaders in the continually evolving field of cancer research.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.isci.2020.101855
发表时间:
2020-12-18
期刊:
iScience
影响因子:
5.8
作者:
[Costa-Pinheiro P, Heher A, Raymond MH, Jividen K, Shaw JJ, Paschal BM, Walker SJ, Fox TE, Kester M]
通讯作者:
Kester M
Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
产生 IL-2 依赖性溶细胞 T 淋巴细胞 (CTL),其 TCR 反应发生改变,源自抗原依赖性 CTL 克隆。
DOI:
--
发表时间:
1999
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Gullo,CA, Esser,MT, Fuller,CL, LamBraciale,V]
通讯作者:
LamBraciale,V
Nucleotide sequence of the btuCED genes involved in vitamin B12 transport in Escherichia coli and homology with components of periplasmic-binding-protein-dependent transport systems.
参与大肠杆菌中维生素 B12 转运的 btuCED 基因的核苷酸序列以及与周质结合蛋白依赖性转运系统成分的同源性。
DOI:
10.1128/jb.167.3.928-934.1986
发表时间:
1986
期刊:
Journal of bacteriology
影响因子:
3.2
作者:
[Friedrich,MJ, deVeaux,LC, Kadner,RJ]
通讯作者:
Kadner,RJ
DOI:
10.1084/jem.187.7.1057
发表时间:
1998-04-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Esser MT, Haverstick DM, Fuller CL, Gullo CA, Braciale VL]
通讯作者:
Braciale VL
DOI:
10.1083/jcb.133.3.559
发表时间:
1996-05
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Danieli T, Pelletier SL, Henis YI, White JM]
通讯作者:
White JM
共 26 条
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
-
批准号:10356164
-
项目类别:
-
资助金额:$56.85万
-
财政年份:2021
-
负责人:Andrew Carl Dudley
-
依托单位:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
-
批准号:10179715
-
项目类别:
-
资助金额:$60.97万
-
财政年份:2021
-
负责人:Andrew Carl Dudley
-
依托单位:
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
-
批准号:10573196
-
项目类别:
-
资助金额:$56.85万
-
财政年份:2021
-
负责人:Andrew Carl Dudley
-
依托单位:
Mechanisms of tumor escape from anti-angiogenic therapy
-
批准号:8693221
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2014
-
负责人:Andrew Carl Dudley
-
依托单位:
Mechanisms of tumor escape from anti-angiogenic therapy
-
批准号:8887312
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2014
-
负责人:Andrew Carl Dudley
-
依托单位:
Targeting the vasculature to enhance anti-tumor immunity
-
批准号:10399410
-
项目类别:
-
资助金额:$35.61万
-
财政年份:2014
-
负责人:Andrew Carl Dudley
-
依托单位:
Targeting the vasculature to enhance anti-tumor immunity
-
批准号:10092966
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2014
-
负责人:Andrew Carl Dudley
-
依托单位:
Targeting the vasculature to enhance anti-tumor immunity
-
批准号:10621205
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2014
-
负责人:Andrew Carl Dudley
-
依托单位:
Tumor endothelial cell abnormalities
-
批准号:8325609
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Andrew Carl Dudley
-
依托单位:
Characterizing tumor endothelial cell abnormalities to develop rational anti-angi
-
批准号:7708266
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2009
-
负责人:Andrew Carl Dudley
-
依托单位:
Characterizing tumor endothelial cell abnormalities to develop rational anti-angi
-
批准号:8231654
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2009
-
负责人:Andrew Carl Dudley
-
依托单位:
Tumor endothelial cell abnormalities
-
批准号:8312046
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Andrew Carl Dudley
-
依托单位:
Tumor endothelial cell abnormalities
-
批准号:8526412
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2009
-
负责人:Andrew Carl Dudley
-
依托单位:
海外基金